OBJECTIVE: Factor XI (FXI) promotes hemostasis and thrombosis through enhancement of thrombin generation and has been shown to play a critical role in the formation of occlusive thrombi in arterial injury models. The aim of this study was to investigate the mechanisms governing interactions between FXI and platelets. METHODS AND RESULTS: Platelet adhesion to immobilized FXI was abrogated in the presence of the low-density lipoprotein (LDL) receptor antagonist, receptor-associated protein (RAP), soluble recombinant apolipoprotein E receptor 2 (ApoER2), or the LDL-binding domain 1 or 2 of ApoER2. FXI supported wild-type murine platelet binding; in contrast, ApoER2-deficient murine platelets did not adhere to FXI. In the presence of shear, platelet aggregates formed on FXI or activated FXI (FXIa) surfaces, whereas the presence of RAP, binding domain 1 of ApoER2, or an anti-GPIb alpha mAb blocked platelet adhesion to FXI or FXIa under shear. Soluble FXI bound to immobilized ApoER2' with an affinity of 61 nmol/L. CONCLUSIONS: This study has identified apolipoprotein E receptor 2 (ApoER2, LRP8), a member of the LDL receptor family, as a platelet receptor for FXI. The interaction of FXI with other cell types that express ApoER2 remains to be explored.
OBJECTIVE: Factor XI (FXI) promotes hemostasis and thrombosis through enhancement of thrombin generation and has been shown to play a critical role in the formation of occlusive thrombi in arterial injury models. The aim of this study was to investigate the mechanisms governing interactions between FXI and platelets. METHODS AND RESULTS: Platelet adhesion to immobilized FXI was abrogated in the presence of the low-density lipoprotein (LDL) receptor antagonist, receptor-associated protein (RAP), soluble recombinant apolipoprotein E receptor 2 (ApoER2), or the LDL-binding domain 1 or 2 of ApoER2. FXI supported wild-type murine platelet binding; in contrast, ApoER2-deficient murine platelets did not adhere to FXI. In the presence of shear, platelet aggregates formed on FXI or activated FXI (FXIa) surfaces, whereas the presence of RAP, binding domain 1 of ApoER2, or an anti-GPIb alpha mAb blocked platelet adhesion to FXI or FXIa under shear. Soluble FXI bound to immobilized ApoER2' with an affinity of 61 nmol/L. CONCLUSIONS: This study has identified apolipoprotein E receptor 2 (ApoER2, LRP8), a member of the LDL receptor family, as a platelet receptor for FXI. The interaction of FXI with other cell types that express ApoER2 remains to be explored.
Authors: Suzanne J A Korporaal; C Arnold Koekman; Sandra Verhoef; Dianne E van der Wal; Martineke Bezemer; Miranda Van Eck; Jan-Willem N Akkerman Journal: Arterioscler Thromb Vasc Biol Date: 2008-12-18 Impact factor: 8.311
Authors: Eric G Huizinga; Shizuko Tsuji; Roland A P Romijn; Marion E Schiphorst; Philip G de Groot; Jan J Sixma; Piet Gros Journal: Science Date: 2002-08-16 Impact factor: 47.728
Authors: Erik I Tucker; Norah G Verbout; Philberta Y Leung; Sawan Hurst; Owen J T McCarty; David Gailani; András Gruber Journal: Blood Date: 2012-03-22 Impact factor: 22.113
Authors: Asako Itakura; Norah G Verbout; Kevin G Phillips; Robert H Insall; David Gailani; Erik I Tucker; Andras Gruber; Owen J T McCarty Journal: J Leukoc Biol Date: 2011-08-01 Impact factor: 4.962
Authors: Erik I Tucker; Ulla M Marzec; Michelle A Berny; Sawan Hurst; Stuart Bunting; Owen J T McCarty; András Gruber; Stephen R Hanson Journal: Sci Transl Med Date: 2010-06-23 Impact factor: 17.956
Authors: Jevgenia Zilberman-Rudenko; Asako Itakura; Chantal P Wiesenekker; Ralf Vetter; Coen Maas; David Gailani; Erik I Tucker; András Gruber; Christoph Gerdes; Owen J T McCarty Journal: Arterioscler Thromb Vasc Biol Date: 2016-01-14 Impact factor: 8.311
Authors: Yipeng Geng; Ingrid M Verhamme; Stephen B Smith; Mao-Fu Sun; Anton Matafonov; Qiufang Cheng; Stephanie A Smith; James H Morrissey; David Gailani Journal: Blood Date: 2013-03-20 Impact factor: 22.113